Cdk4 and nek2 signal binucleation and centrosome amplification in a her2+ breast cancer model.
about
Centrosome - a promising anti-cancer targetPrognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors.Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosisE2F activators signal and maintain centrosome amplification in breast cancer cells.Differential expression of centrosome regulators in Her2+ breast cancer cells versus non-tumorigenic MCF10A cells.Nek2 is a novel regulator of B cell development and immunological response.Role of NEK2A in human cancer and its therapeutic potentials.Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosisTargeting NEK2 as a promising therapeutic approach for cancer treatment.Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis.Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance.MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma.The E2F activators control multiple mitotic regulators and maintain genomic integrity through Sgo1 and BubR1.Importance of protein flexibility on molecular recognition: modeling binding mechanisms of aminopyrazine inhibitors to Nek2.Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity
P2860
Q28077520-5F39F69D-BB23-4224-AB03-C2B86D26558EQ33671140-64130EC0-CDF4-4E3E-BDD7-F2F30A38F4C2Q33802966-97137A06-C93C-409C-90C8-43165A99E93DQ33899840-CE8E9FAB-9696-46BF-A559-94EFC7057432Q34273997-DAE88F55-1907-44D0-BBCA-90F5E3E2A8DCQ34609883-EB5093DB-15C7-46A5-A9E5-47395772B9F0Q35090475-F9CFE9C6-3DC6-49A9-8872-58C2032B4E7DQ36545731-32F8F3C4-D225-4B76-BB32-C5E6361650B1Q36956969-B0C8C23B-59EF-4252-BD98-3AC437EBDA58Q37071327-6CCB1D69-8A19-4DC1-B400-02FD533D306DQ37723758-ECF1803B-0FDE-4C98-8E5D-E9CDDB631DA5Q41592983-1EDD1DEB-5C82-4749-8BA5-308E99467EB0Q47109520-B545F88A-4B7C-48C8-8F26-045B1B60E1EEQ47225930-688F4FF6-3AB1-411E-AAE3-349E6C6B386CQ58132668-2BBA6840-0AF6-4E5A-B098-7D328849B462
P2860
Cdk4 and nek2 signal binucleation and centrosome amplification in a her2+ breast cancer model.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Cdk4 and nek2 signal binucleat ...... n a her2+ breast cancer model.
@ast
Cdk4 and nek2 signal binucleat ...... n a her2+ breast cancer model.
@en
Cdk4 and nek2 signal binucleat ...... n a her2+ breast cancer model.
@nl
type
label
Cdk4 and nek2 signal binucleat ...... n a her2+ breast cancer model.
@ast
Cdk4 and nek2 signal binucleat ...... n a her2+ breast cancer model.
@en
Cdk4 and nek2 signal binucleat ...... n a her2+ breast cancer model.
@nl
prefLabel
Cdk4 and nek2 signal binucleat ...... n a her2+ breast cancer model.
@ast
Cdk4 and nek2 signal binucleat ...... n a her2+ breast cancer model.
@en
Cdk4 and nek2 signal binucleat ...... n a her2+ breast cancer model.
@nl
P2860
P1433
P1476
Cdk4 and nek2 signal binucleat ...... n a her2+ breast cancer model.
@en
P2093
Harold I Saavedra
Mary Kathryn Harrison Pitner
P2860
P304
P356
10.1371/JOURNAL.PONE.0065971
P407
P577
2013-06-11T00:00:00Z